InspireMD (NSPR) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 10.07% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.57% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 9.71% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 17.92% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 3.47% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 13.19% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.97% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 9.80% |
| 10 | InspireMD | 64.01 Mn | 9.80 Mn | 1.18 Mn | 57.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 57.52% |
| Sep 30, 2025 | 57.20% |
| Jun 30, 2025 | 64.24% |
| Mar 31, 2025 | 63.32% |
| Dec 31, 2024 | 55.38% |
| Sep 30, 2024 | 51.20% |
| Jun 30, 2024 | 53.27% |
| Mar 31, 2024 | 41.12% |
| Dec 31, 2023 | 33.25% |
| Sep 30, 2023 | 29.77% |
| Jun 30, 2023 | 23.90% |
| Mar 31, 2023 | 21.38% |
| Dec 31, 2022 | 18.79% |
| Sep 30, 2022 | 17.65% |
| Jun 30, 2022 | 10.92% |
| Mar 31, 2022 | 11.59% |
| Dec 31, 2021 | 14.50% |
| Sep 30, 2021 | 12.07% |
| Jun 30, 2021 | 0.92% |
| Mar 31, 2021 | -1.68% |
| Dec 31, 2020 | -2.00% |
| Sep 30, 2020 | -5.71% |
| Jun 30, 2020 | 0.00% |
| Mar 31, 2020 | 0.00% |
| Dec 31, 2019 | 13.01% |
| Sep 30, 2019 | 12.39% |
| Jun 30, 2019 | 7.58% |
| Dec 31, 2018 | -3.74% |
| Jun 30, 2018 | -7.58% |
| Dec 31, 2017 | -8.53% |
| Jun 30, 2017 | -11.54% |
| Mar 31, 2017 | -7.37% |
| Dec 31, 2016 | -16.54% |
| Sep 30, 2016 | -13.76% |
| Jun 30, 2016 | -9.18% |
| Dec 31, 2015 | -0.49% |
| Jun 30, 2015 | 5.73% |
| Dec 31, 2014 | 13.98% |
| Jun 30, 2014 | 29.68% |
| Dec 31, 2013 | 32.23% |